Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylamide SCHEMBL28918491 | 0.88 | ALDH1A1 (0.73) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL16402988 | 0.88 | ALDH1A1 (0.73) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL2160931 | 0.88 | ALDH1A1 (0.73) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL29092492 | 0.88 | ALDH1A1 (0.73) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL27770486 | 0.85 | ALDH1A1 (0.69) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL28807078 | 0.85 | ALDH1A1 (0.69) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL3255310 | 0.85 | ALDH1A1 (0.69) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL5807989 | 0.85 | ALDH1A1 (0.69) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL28734833 | 0.85 | ALDH1A1 (0.69) | ALDH1A1TSHRFGFR4LMNACA4 | |
| Acrylamide SCHEMBL4338828 | 0.82 | ALDH1A1 (0.65) | ALDH1A1TSHRFGFR4LMNACA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001043710-A1 | MONOFLUORO PHOSPHORYLATED MACROMOLECULES | UNILEVER N.V. (NL) | 2001-06-21 | — | — | WO | disclosed |